Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues
NIBIB - National Institute of Biomedical Imaging and Bioengineering
About This Grant
Abstract With the progress in vascular bioengineering, three-dimensional (3D) bioprinting has emerged as a potential approach for generating physiologically relevant blood vessels with the ability to grow, remodel, and repair vascular structures in vitro and in vivo. Different 3D bioprinting techniques and strategies have been investigated and established over the past years to fabricate biomimetic blood vessels and are constantly being refined and improved. To this end, sacrificial bioprinting technologies developed in the past few years have provided a convenient solution for this problem due to its capability to fabricate interconnected microchannels of arbitrary geometries and connectivity. However, although sacrificial bioprinting provides a versatile method to create vessel-like structures, there are two major obstacles preventing its further growth, i.e., the patterns attainable are relatively simple, and the resolutions attainable for the perfusable vessels are insufficient in most cases, both due to the extrusion bioprinting method that has been exclusively utilized in sacrificial bioprinting so far. We accordingly propose to develop an innovative hybrid multi-material and multi- method autonomous printing (HM2AP) technology integrating aerosol jet sacrificial printing and extrusion bioprinting, which enables facile construction of 3D complex and hierarchical vascular structures with feature sizes ranging from 10-100 µm embedded within tissue microenvironments. Successful completion of this project will build a paradigm-shifting bioprinting technology using which complex and hierarchical vessels of varying dimensions can be readily generated.
Grant Summary
Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues is a NIBIB - National Institute of Biomedical Imaging and Bioengineering grant providing up to $663K for university, nonprofit, healthcare org. Applications are due 2030-02-28 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $663K
2030-02-28
- 1Confirm your organization is eligible for Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues from NIBIB - National Institute of Biomedical Imaging and Bioengineering, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIBIB - National Institute of Biomedical Imaging and Bioengineering before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIBIB - National Institute of Biomedical Imaging and Bioengineering's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues: Frequently Asked Questions
Who is eligible for the Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues?
Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues is offered by NIBIB - National Institute of Biomedical Imaging and Bioengineering and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues provide?
Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues provides up to $663K per award from NIBIB - National Institute of Biomedical Imaging and Bioengineering. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues deadline?
Applications for Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues are due 2030-02-28 (open). Because deadlines can change, verify the date with the funder, NIBIB - National Institute of Biomedical Imaging and Bioengineering, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues?
To apply for Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver Tissues, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIBIB - National Institute of Biomedical Imaging and Bioengineering.